Dr. Huffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Boston, MA 02215- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2020 - 2023
- Mayo Clinic College of Medicine and Science (Rochester)Chief Residency, Internal Medicine, 2019 - 2020
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
- University of Missouri-Columbia School of MedicineClass of 2015
Certifications & Licensure
- MA State Medical License 2020 - 2024
- MN State Medical License 2016 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- ZN-c3 + Gemcitabine in Pancreatic Cancer Start of enrollment: 2023 Nov 16
Roles: Sponsor-Investigator, Principal Investigator, Contact
Publications & Presentations
PubMed
- Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada L...> ;NPJ Precision Oncology. 2024 May 6
- RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Eliza...> ;Clinical Cancer Research. 2024 Apr 15
- Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak, Pornlada L...> ;NPJ Precision Oncology. 2024 Apr 8
- Join now to see all
Press Mentions
- Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational UpdatesNovember 9th, 2022
- Natera Releases New Clinical Data at ESMO 2021 in Gastroesophageal Cancer and Uveal MelanomaSeptember 17th, 2021
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: